# | Name | Compound Key | Action Type | Relation | Activity Value | Units | Assay ID | Assay Description | Comment | Assay | Assay Organism | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | ALA4202767 | 56 | Activity | <= | 25 | % | ALA4187141 | % | Homo sapiens | |||
2. | ABT 724 | 3a | % inhibition | < | 10 | % | ALA4880386 | Not Active | % | Homo sapiens | ||
3. | ALA111612 | 10a | % inhibition | < | 10 | % | ALA4880301 | Not Active | % | Homo sapiens | ||
4. | ABT-100 | EUB0000289 | % inhibition | 13 | % | ALA4880225 | Not Active | % | Homo sapiens | |||
5. | ALA3697701 | BDBM161012 | % inhibition | -4 | % | ALA4880112 | Not Active | % | Homo sapiens | |||
6. | ALA3334797 | 36a | INH | = | 3.2 | % | ALA3370823 | % | Homo sapiens | |||
7. | ALA1807053 | 59, NGD 98-2 | INH | > | 16 | % | ALA1809427 | % | Homo sapiens | |||
8. | ALA426548 | 38 | IC50 | = | 0.64 | nM | ALA918952 | 9.19 | nM | Homo sapiens | ||
9. | ALA376484 | 37 | IC50 | = | 0.5 | nM | ALA918952 | 9.30 | nM | Homo sapiens | ||
10. | ALA268060 | 35 | IC50 | = | 1.6 | nM | ALA918952 | 8.80 | nM | Homo sapiens | ||
11. | ALA376485 | 34 | IC50 | = | 0.35 | nM | ALA918952 | 9.46 | nM | Homo sapiens | ||
12. | ALA222699 | 29 | IC50 | = | 1.6 | nM | ALA918952 | 8.80 | nM | Homo sapiens | ||
13. | ALA3350037 | Octreotide | IC50 | = | 1.1 | nM | ALA918952 | 8.96 | nM | Homo sapiens | ||
14. | ALA437296 | 39, p2045 | IC50 | = | 0.2 | nM | ALA918952 | 9.70 | nM | Homo sapiens | ||
15. | ALA214585 | 12 | IC50 | > | 10 | uM | ALA907668 | nM | Homo sapiens | |||
16. | ALA217053 | 19 | Inhibition | < | 30 | % | ALA911176 | % | Homo sapiens | |||
17. | PHA-543613 | 14, PHA-543613 | Inhibition | < | 10 | % | ALA854428 | % | Homo sapiens | |||
18. | ALA411941 | Cyclo (RGDfV) | Ki | 0 | ALA862262 | Not Determined | Homo sapiens | |||||
19. | Naluzotan | 20m | Ki | > | 2 | uM | ALA862262 | nM | Homo sapiens | |||
20. | ALA382109 | 95 | IC50 | = | 47 | uM | ALA882125 | 4.33 | nM | Homo sapiens |